ICMR to conduct trials of indigenously developed Zika vaccine
The Economics Times Nov. 18, 2018 NEW DELHI: The Indian Council of Medical Research (ICMR) will soon undertake trials of the indigenously developed vaccine against Zika virus, cases of which have been reported in Madhya Pradesh, Rajasthan and Gujarat. The ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects, a senior official said. Vaccines manufacturer, Hyderabad-based Bharat Biotech, has developed a vaccine, which they claim will provide protection against infection caused by an Asian Zika virus strain as well as by the African Zika virus strain, the official said. "The company had developed the vaccine around two years ago. At that time we did not have an outbreak of Zika in India as it was only restricted to Latin America. Â "Zika virus is spread to people primarily through the bite of an infected Aedes species mosquito and also there is a breakout in some sta...